LFG
AUPH icon

Larson Financial Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Larson Financial Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.11K Buy
615
+273
+80% +$3.99K ﹤0.01% 2299
2025
Q4 		$5.46K Buy
342
+13
+4% +$184 ﹤0.01% 2423
2025
Q3 		$3.63K Buy
+329
New +$3.59K ﹤0.01% 2475

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Larson Financial Group's AUPH Position: Q1 2026 in Review

Larson Financial Group increased its Aurinia Pharmaceuticals (AUPH) stake by 80% in Q1 2026, buying an estimated $3.99K and bringing the position to 615 shares worth $9.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2299.

Larson Financial Group first reported a position in AUPH in Q3 2025 and has held it in 3 quarters since. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Larson Financial Group held 615 shares of Aurinia Pharmaceuticals worth $9.11K as of Q1 2026.
  • Larson Financial Group bought 273 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $3.99K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2299 holding.
  • Larson Financial Group first reported a position in Aurinia Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.